Early diagnosis, treatment of AMD essential for lifelong healthy vision

Article

Vision loss in relation to eye disease and treatment response was tracked in nearly 5,000 patients over 20 years.

 

San Francisco-Despite the recent discovery of sight-saving drugs and advances in disease prevention, age-related macular degeneration (AMD) still causes vision loss in approximately 15% of Americans aged 85 and older, according to a study published recently in Ophthalmology.

The Beaver Dam Eye Study tracked vision loss in relation to eye disease and treatment response in nearly 5,000 patients over a 20-year period.

“This study paints a clearer picture of key threats to older Americans’ vision, such as AMD,” said Ronald Klein, MD, lead researcher for the study conducted at the University of Wisconsin School of Medicine and Public Health, Madison. “It is especially relevant for healthcare planners, who face a tripling of the elderly population in the U.S. More people than ever will live into their seventh, eighth, or ninth decades, the very years when they’ll be most vulnerable to age-related eye diseases.”

Healthy vision is essential to seniors’ ability to enjoy a good quality of life. From maintaining the ability to read and drive to reducing the risk of injury from falls and other accidents, keeping eyes healthy into advanced age is crucial.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.